Miscellaneous Glutamate
Miscellaneous Glutamate Inhibitors |
|
|---|---|
| Cat. No. | Product Name / Activity |
| 1380 | PMPA (NAALADase inhibitor) |
| Highly potent, selective NAALADase (GCP II) inhibitor | |
| 0768 | Riluzole hydrochloride |
| Glutamate release inhibitor; also inhibits GABA uptake and blocks NaV channels | |
| 2675 | ZJ 43 |
| Glutamate carboxypeptidase II and III (NAALADase, NAAG peptidase) inhibitor | |
Other |
|
| Cat. No. | Product Name / Activity |
| 2538 | L-BMAA hydrochloride |
| Neurotoxic amino acid | |
| 1611 | Lamotrigine |
| Inhibits glutamate release. Anticonvulsant | |
| 2289 | Lamotrigine isethionate |
| Inhibits glutamate release. Water-soluble salt of lamotrigine (Cat. No. 1611) | |
| 1490 | MNI-caged-L-glutamate |
| Stable photoreleaser of L-glutamate | |
| 2687 | Pentylenetetrazole |
| CNS stimulant | |
| 3574 | RuBi-Glutamate |
| Caged glutamate; excited by visible wavelengths | |
| 2625 | Zonisamide |
| Anticonvulsant, modulates glutamate neurotransmission | |
mGlu Receptors Scientific Review
Our Metabotropic Glutamate Receptor review gives an overview of the pharmacological ligands used to study the mGlu receptors.
Request copyRequest PDFDepression Life Science Poster
Written by P. Skolnich et al
Our Depression poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder.
Request copyDownload PDFParkinson's Life Science Poster
Written by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDF